For the quarter ended March 2024, Stepan Co. (SCL - Free Report) reported revenue of $551.42 million, down 15.4% over the same period last year. EPS came in at $0.64, compared to $0.71 in the year-ago quarter.
The reported revenue represents a surprise of -4.24% over the Zacks Consensus Estimate of $575.83 million. With the consensus EPS estimate being $0.35, the EPS surprise was +82.86%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Stepan Co. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Specialty products: $15.09 million versus $19.65 million estimated by two analysts on average.
- Net Sales- Polymers: $145.51 million compared to the $160.50 million average estimate based on two analysts. The reported number represents a change of -9.7% year over year.
- Net Sales- Surfactants: $390.82 million versus $402.60 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -16.5% change.
- Operating income- Surfactants: $26.08 million versus the two-analyst average estimate of $20.45 million.
- Operating income- Specialty Products: $4.27 million compared to the $3.50 million average estimate based on two analysts.
- Operating income- Polymers: $8.38 million versus $11.55 million estimated by two analysts on average.
View all Key Company Metrics for Stepan Co. here>>>Shares of Stepan Co. have returned -4.4% over the past month versus the Zacks S&P 500 composite's -2.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
For the quarter ended March 2024, Stepan Co. (SCL - Free Report) reported revenue of $551.42 million, down 15.4% over the same period last year. EPS came in at $0.64, compared to $0.71 in the year-ago quarter.
The reported revenue represents a surprise of -4.24% over the Zacks Consensus Estimate of $575.83 million. With the consensus EPS estimate being $0.35, the EPS surprise was +82.86%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Stepan Co. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Specialty products: $15.09 million versus $19.65 million estimated by two analysts on average.
- Net Sales- Polymers: $145.51 million compared to the $160.50 million average estimate based on two analysts. The reported number represents a change of -9.7% year over year.
- Net Sales- Surfactants: $390.82 million versus $402.60 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -16.5% change.
- Operating income- Surfactants: $26.08 million versus the two-analyst average estimate of $20.45 million.
- Operating income- Specialty Products: $4.27 million compared to the $3.50 million average estimate based on two analysts.
- Operating income- Polymers: $8.38 million versus $11.55 million estimated by two analysts on average.
View all Key Company Metrics for Stepan Co. here>>>Shares of Stepan Co. have returned -4.4% over the past month versus the Zacks S&P 500 composite's -2.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on SCL - FREE